Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.

Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB.

Int J Cancer. 2012 Aug 1;131(3):E292-303. doi: 10.1002/ijc.26442. Epub 2011 Nov 9.

2.

Effect of NF-κB inhibition on chemoresistance in biliary-pancreatic cancer.

Uwagawa T, Yanaga K.

Surg Today. 2015 Dec;45(12):1481-8. doi: 10.1007/s00595-015-1129-z. Epub 2015 Feb 12. Review.

PMID:
25673034
3.

Therapeutic applications of curcumin for patients with pancreatic cancer.

Kanai M.

World J Gastroenterol. 2014 Jul 28;20(28):9384-91. doi: 10.3748/wjg.v20.i28.9384. Review.

Supplemental Content

Support Center